Armstrong Advisory Group’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Armstrong Advisory Group's HALO Position: Q3 2026 in Review
Armstrong Advisory Group held its Halozyme (HALO) position steady in Q3 2026 at 300 shares worth $33.1K. The position accounts for ﹤0.01% of the portfolio, ranked #493.
Armstrong Advisory Group first reported a position in HALO in Q3 2024 and has held it in 9 quarters since. 172 funds tracked by Wall St. Rank hold HALO as of Q3 2026.
- Armstrong Advisory Group held 300 shares of Halozyme worth $33.1K as of Q3 2026.
- Armstrong Advisory Group left its Halozyme share count unchanged in Q3 2026.
- Halozyme made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q3 2026, its #493 holding.
- Armstrong Advisory Group first reported a position in Halozyme in Q3 2024 and has held it in 9 quarters since.
- 172 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.
Based on Armstrong Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.